News

Innocan Pharma Showcases Innovative CBD Technology at Conference

Innocan Pharma Showcases Innovative CBD Technology at Conference

Innocan Pharma’s Groundbreaking Presentation at PAINWeek

Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) has stirred excitement during its recent presentation at a premier conference dedicated to pain medicine. Dr. Joseph V. Pergolizzi, Jr., MD, MBA, unveiled the company's innovative LPT-CBD technology, which generated a significant buzz among industry leaders and attendees alike.

Captivating the Audience with Innovative Solutions

At the event, the interest surrounding Innocan's poster presentation stood out remarkably. Leading voices in pain management, including prominent researchers and clinicians, expressed enthusiasm for the potential impact of long-acting synthetic CBD treatments on pain relief. This excitement signals a shift toward innovative methodologies in addressing chronic pain.

Recognition from Industry Peers

The poster presentation has been recognized by influential platforms like Pain Medicine News, which plans a dedicated interview featuring Innocan’s advancements. Experts highlighted the critical evaluation of plant-derived CBD oils, presenting a case for the necessity of regulated, long-acting synthetic CBD therapies.

Highlighting the Limitations and Opportunities

Doctor Pergolizzi's presentation included a narrative review that critically examined the limitations of existing plant-derived CBD oils in managing chronic pain. He presented compelling preclinical data showcasing the pharmacokinetics of LPT-CBD, illustrating its potential for prolonged pain relief following a single administration in animal studies.

The Unique Proposition of LPT-CBD

Dr. Pergolizzi remarked, "The enthusiasm in the room was palpable because this technology represents a true breakthrough opportunity to address longstanding unmet needs in pain management." He emphasized that for many patients, LPT-CBD could signify a life-altering improvement, offering relief from chronic pain complaints that have long remained unanswered.

Company Leadership Enthusiasm

Iris Bincovich, Innocan's CEO, echoed the optimism surrounding their technology: "We are thrilled to present our unique solutions to a diverse audience of leaders in the field. The warm reception at PAINWeek underscores our commitment to advancing evidence-based solutions that truly benefit patients and healthcare providers alike."

About Innocan Pharma

Innocan is a frontrunner in the pharmaceutical domain, focusing on innovative solutions in the wellness and healthcare sectors. The company has developed a specialized drug delivery platform utilizing CBD-loaded liposomes, aimed at non-opioid pain management through precise dosing and sustained release mechanisms. Additionally, Innocan also markets high-performance self-care products intended to enrich health and wellness.

Corporate Information and Contact Details

For further inquiries regarding Innocan Pharma Corporation, please reach out to:
Innocan Pharma Corporation
Iris Bincovich, CEO
+1 5162104025
+972-54-3012842
+442037699377

Frequently Asked Questions

What is Innocan's main area of focus?

Innocan Pharma specializes in developing innovative pharmaceutical products, particularly focusing on pain management solutions using synthetic CBD technologies.

What was presented at the PAINWeek conference?

The presentation showcased Innocan's LPT-CBD technology, highlighting its potential benefits for patients suffering from chronic pain.

Who presented the findings at the conference?

Dr. Joseph V. Pergolizzi, Jr., MD, MBA, represented Innocan Pharma and shared insights on the company's innovative CBD technology.

How is LPT-CBD different from plant-derived CBD?

LPT-CBD is a synthetic formulation that aims to provide more consistent dosing and prolonged relief compared to traditional plant-derived CBD products.

What are the future plans for Innocan Pharma?

Innocan aims to advance its research and strengthen partnerships in the pharmaceutical industry to improve patient care and expand its product offerings.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

China's APEC Summit: A Catalyst for Business Growth?

Updated Category News Views 48

A Shift Toward Regional Stability China's position as this year's APEC rotating chair presents both opportunity and challenge as economies grapple with trade barriers and technological upheaval. The 33rd APEC Economic Leaders' Meeting in Shenzhen is intended to navigate these turbulent waters, setting the stage for a more stable regional environment. APEC's Role in...

Continue Reading
Sue Egstrand to Lead Karo's Next Growth Phase

Updated Category News Views 117

A New Captain at Karo’s Helm Karo Healthcare is bracing for an exciting ride. Sue Egstrand’s appointment as the new CEO pulls the curtain on what might just be a game-changing era for the company. Set to take the wheel on January 1, 2027, Egstrand brings a heavy-hitting resume—a mash-up of pharmaceutical prowess and a deep-dive into consumer healthcare. Sue’s...

Continue Reading
Gaotu Techedu's Q3 Results: A Look at AI-Driven Growth

Updated Category News Views 56

Gaotu Techedu to Unveil Q3 Results Mark your calendars, folks—Gaotu Techedu Inc. (NYSE: GOTU) is gearing up to dish out its third quarter financial results on November 25, 2026. As usual, these numbers will slide out before the U.S. markets spring into action. It's one of those moments when investors like us strap in and watch for any movement that might toss our...

Continue Reading
Gold Tumbles: Kinross Faces Class Action Lawsuit

Updated Category News Views 79

Digging Deep into Kinross's Legal Fallout Well, here's a doozy for those investing in the precious metal market. Kinross Gold Corporation (NYSE: KGC) finds itself knee-deep in legal muck. Investors who bought into the Canadian gold miner's promises might be scrambling, as a class action lawsuit has just been lobbed their way. The culprit? A hefty drop-off in their...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 382

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
Atomera Preps for Key Craig-Hallum Conference

Updated Category News Views 59

Unpacking the NYC Gathering Alight, let's comb through the moving parts here. Atomera Inc., ticker NASDAQ: ATOM for those eyeing the dance of numbers, is all set to step into the limelight at the 17th Annual Craig-Hallum Alpha Select Conference on November 17, 2026. This shindig isn't just another date on the calendar; it's a strategic haunt where Atomera will rub...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 421

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Envision and Tsinghua Propel Climate Innovation at COP31

Updated Category News Views 87

Collaborating for a Greener Future On the bustling stage of COP31 in Antalya, Turkey, Envision Energy and Tsinghua University teamed up with the Global Alliance of Universities on Climate (GAUC) to showcase a bold agenda. Their focus transcends mere dialogue, pushing for actionable climate solutions anchored in technological innovation, academic synergy, and the dynamism...

Continue Reading
Roche Delivers Endotrophin Assay to Nordic Bioscience Lab

Updated Category News Views 52

Roche Opens New Frontier in Diagnostic Biomarkers Get ready to chew on this: Roche Diagnostics is bringing something new to Nordic Bioscience's CLIA lab. They're offering up their Endotrophin research prototype assay on the cobas® e801 Analyzer. Now, what does this mean for the scientific world? Well, it might just shake things up for those battling cardiovascular and...

Continue Reading
Asia-Pacific Miracle: New Economic Chapter Unfolds

Updated Category News Views 87

A Fresh Breeze in Asia-Pacific's Sails You ever look around and realize everything's about to change—again? That's Asia-Pacific right now. We're staring down the barrel of a new chapter in what folks are calling the "Asia-Pacific miracle." The text from China Daily paints a picture of a region gearing up to crank the cooperation dial even higher. And where's this...

Continue Reading

Top 5 Most Recently Viewed Articles

Choice Hotels Unveils Comprehensive Sustainability Efforts

Updated Category News Views 387

Choice Hotels International Launches 2024 Sustainability Report Choice Hotels International, Inc. (NYSE: CHH), a leading global lodging franchisor, has officially released its 2024 Sustainability Report, showcasing its ongoing commitment to environmental sustainability. The report highlights the company's innovative approaches to reducing its carbon footprint and...

Continue Reading
Revitalizing Communities Through Skilled Trades Initiatives

Updated Category News Views 157

Revitalizing Communities Through Skilled Trades Initiatives In an important moment for many towns across America that are striving for renewal, a new initiative has emerged to shine a light on the necessity of skilled trades. The campaign, titled Careers in Manufacturing, is aimed at highlighting how vital these trades are for both local economies and the workforce on the...

Continue Reading
Color Me Mine Celebrates Growth and Franchise Success

Updated Category News Views 344

Color Me Mine Achieves Remarkable Mid-Year Growth Color Me Mine, a leading paint-your-own pottery franchise, is excited to announce significant growth through its studio expansion and franchisee success. The brand is witnessing a thriving landscape of opportunities, fueled by enthusiastic franchise owners who are making their mark in various communities. Studio Expansion...

Continue Reading
Earnings Insights: Companies Set to Report Soon

Updated Category News Views 202

Upcoming Earnings Reports for Major Companies As the earnings season approaches, investors and analysts eagerly anticipate the financial results from several prominent companies. This article highlights some of the key players expected to announce their quarterly results. Companies Reporting Before the Market Opens UP Fintech Holding (TIGR) UP Fintech Holding is projected...

Continue Reading
Cogent Biosciences Shares Insights at Prestigious Healthcare Event

Updated Category News Views 207

Cogent Biosciences Highlights Participation in Major Healthcare Conference Cogent Biosciences, Inc. (Nasdaq: COGT), a pioneering biotechnology company, is ready to showcase its innovative approach to precision medicine at the highly regarded J.P. Morgan Healthcare Conference. Taking place in San Francisco, this annual event is a crucial platform for industry leaders to...

Continue Reading